Will Cozean

Will Cozean is a Managing Director at Bain Capital Life Sciences based in Melbourne. He joined the firm in 2013, initially serving on the North America Private Equity team across the healthcare, industrials, and technology verticals after working as a consultant at McKinsey and Company from 2011 to 2013. In his current capacity, he directs private equity investments and recently led a $200 million strategic growth transaction for Serán BioScience, where he serves as a board member alongside his directorship at Kailera Therapeutics. He also holds board observer roles at AreteiaTx, Cardurion Pharmaceuticals, and Cerevel Therapeutics, drawing on an academic foundation that includes an MBA from Harvard Business School and a BS in Commerce from the University of Virginia. Cozean focuses on executing large-scale private equity transactions and driving operational improvements within the life sciences and healthcare sectors.